Renin-angiotensin-system blockade in the prevention of diabetes. Diabetes Res Clin Pract. 2007;76(suppl 1):S13-S21.Ostergren J. Renin-angiotensin-system blockade in the prevention of diabetes. Diabetes Res Clin Pract May 2007;76 Suppl 1:S13- 21....
Renin-angiotensin system blocker discontinua- tion and adverse outcomes in chronic kidney disease. Nephrol Dial Transplant. 2021;36:1893–9. 12. Fu EL, Evans M, Clase CM, Tomlinson LA, van Diepen M, Dekker FW, et al. Stopping renin-angiotensin system inhibitors in patients with advanced CKD...
Grandi AM, Solbiati F, Laurita E, Maresca AM, Nicolini E, Marchesi C, Gianni M, Guasti L, Venco A: Effects of dual blockade of renin-angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study. Am J Hypertens 2008, 21(2):...
3.3Renin-angiotensin system inhibitor Renin–angiotensin system (RAS) inhibitors such as the angiotensin-converting enzyme (ACE) inhibitors andangiotensin receptor blockers(ARBs) may be effective in treatingvasomotor disorderssince RAS is known to be closely associated with endothelial function, andRAS inh...
Re: Dual renin-angiotensin system blockade Some of what Peter de Leeuw states is obvious. It is well known that co-administration of two blockers of the renin angiotensin system may cause renal dysfunction and hyperkalaemia. Even one blocker may do so. That is not the point. What matters...
The acute effects of the renin-angiotensin system (RAS) blockers may be important in some clinical settings. To assess the acute impact of such drugs on arterial function, we studied the effects of captopril 25 mg, quinapril 20 mg and telmisartan 80 mg on 100 hypertensive patients, according...
To determine the frequency of biochemical monitoring after initiation of aldosterone antagonists(AA) in patients also using angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARB). UK primary care. ACEI/ARB users who initiated AA between 2004 and 2014. We calculated the proport...
Depression remains a debilitating condition with an uncertain aetiology. Recently, attention has been given to the renin–angiotensin system. In the central nervous system, angiotensin II may be important in multiple pathways related to neurodevelopment
angiotensin receptor blockerangiotensin-converting-enzyme inhibitorcombination therapydiabetic nephropathydual blockadeAuthor(s): Yolanda E Bogaert [1] [box 1]Jennings DL et al . (2007) Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis...
There is accumulating molecular and in vivo evidence to indicate that the expression and actions of the renin–angiotensin system (RAS) influence malignancy and also predict that RAS inhibitors, which are currently used to treat hypertension and cardiovascular disease, might augment cancer therapies. ...